Stephen Shapiro

Stephen Shapiro

Directeur/Bestuurslid bij
Pacific Diagnostic Laboratories LLC
81 jaar
Health Technology
Finance
Health Services

Profiel

Stephen I.
Shapiro
is currently the Director at Pacific Diagnostic Laboratories LLC and a Venture Partner at ATV Capital Management Inc. He previously held positions as Director of Technology & New Business Development at Becton, Dickinson & Co., Director at Novoste Corp., Director at Closure Medical Corp., Director at Aperio Technologies, Inc., Independent Director at Tactile Systems Technology, Inc., Director at Nuvesse Skin Therapies, Inc., Managing Director at Wilkerson Group, Director at Sonablate Corp., Director at Ajinomoto Cambrooke, Inc., and Principal at Union Carbide Corp.
He also served as a Special Venture Partner at Galen Management LLC and an Advisor at LSV Capital Management LLC.
Shapiro received his undergraduate degree from Massachusetts Institute of Technology and his graduate degree from the University of California, Berkeley.

Actieve functies van Stephen Shapiro

BedrijvenFunctieBegin
Private Equity Investor -
Directeur/Bestuurslid -

Eerdere bekende functies van Stephen Shapiro

BedrijvenFunctieEinde
TACTILE SYSTEMS TECHNOLOGY, INC. Directeur/Bestuurslid 09-05-2017
Directeur/Bestuurslid 06-06-2008
Directeur/Bestuurslid 27-11-2007
Private Equity Investor -
Directeur/Bestuurslid -
Ervaring van Stephen Shapiro in detail bekijken

Opleiding van Stephen Shapiro

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

24

Eerstegraads connecties

17

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit17

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Finance

Health Services

Finance

Consumer Services

Finance

Health Technology

Health Technology

Finance

Health Services

  1. Beurs
  2. Insiders
  3. Stephen Shapiro
-40 %: de beste tools exclusief voor abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU